Koliber Biosciences

Koliber Biosciences has developed an AI assisted peptide drug discovery platform. The platform is ideal for analysis of complex datasets derived from peptide variants that include multiple performance metrics such as activity, selectivity, solubility, and in vivo results. Two classes of encodings are available: classical peptide features such as physiochemical properties and proprietary deep learning encodings.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore organization profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Koliber Biosciences.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Koliber Biosciences has developed an AI assisted peptide drug discovery platform. The platform is ideal for analysis of complex datasets derived from peptide variants that include multiple performance metrics such as activity, selectivity, solubility, and in vivo results. Two classes of encodings are available: classical peptide features such as physiochemical properties and proprietary deep learning encodings.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.